Does red light therapy work for hair loss?

Red light therapy works for hair loss of one particular kind: androgenetic alopecia, the pattern baldness that thins hair slowly at the temples and crown. Two separate pooled analyses of randomised trials found that shining red or near-infrared light on the scalp grew more hair than a dummy device that looked identical but emitted nothing [13][15].

What the trials measure is hair you can count under a camera. In a six-month study, 17 adults with an average age of 46 wore a helmet that lit one half of the front scalp with red light and the other half with green, 20 minutes at a time. The red-lit half ended up with thicker hairs and more full-thickness hairs, and with fewer vellus hairs, the fine pale ones that replace proper hairs as balding advances [1]. Side effects were scalp warmth and mild redness.

Against the drugs, light therapy is not the weak option. A network meta-analysis, which pools trials to rank treatments that were never tested head to head, put low-level laser therapy, the clinical name for this treatment when a laser rather than an LED delivers the light, at the top of six non-surgical options. Platelet-rich plasma injections, finasteride, dutasteride and both strengths of minoxidil came out roughly level with each other below it [15]. A separate meta-analysis, restricted to good and fair quality randomised trials, found that light therapy, minoxidil and finasteride all beat placebo in men [13].

The regulatory position tracks that gap in evidence. One laser comb is cleared by the American regulator for pattern hair loss, while minoxidil and finasteride are approved, which are two different routes [13]. The timescale is months, not weeks: the helmet study read its results at six months [1].

Safety is the settled part. A panel of 21 specialists who reviewed the literature and voted through two rounds of surveys concluded that red light treatment is safe for adults, does not damage DNA, and is effective for pattern hair loss [4]. A dermatology review agrees on safety while calling for trials that would standardise how the treatment is applied across different conditions and skin types [2].

Red light means wavelengths of roughly 620 to 700 nanometres, near-infrared 700 to 1440, where a nanometre is a billionth of a metre. Both pass into the skin and are absorbed inside cells rather than simply heating them, which is why the treatment is called photobiomodulation, light that changes how a cell behaves [2].

The main absorber sits in the mitochondria, the compartments that generate a cell's energy. Reviews describe the downstream result as more ATP, the molecule cells spend as fuel, along with altered cell signalling, more growth factor production and less oxidative stress, the chemical wear that builds up when reactive molecules outpace a cell's ability to clear them [3].

Inside the follicle, two signalling routes have been traced, both in the laboratory rather than in people. Red light made dermal papilla cells, the cluster at the base of each follicle that tells the hair whether to grow, migrate more and release more of the small packets of signalling molecules they use to instruct neighbouring cells; blocking one enzyme in that chain stopped the effect [7]. Low-level laser light also switched on Wnt signalling, a growth programme that pushed hair follicle stem cells to multiply and turn into skin structures [9]. Those results come from mice and cell cultures.

The direction of the effect is better established than its size. The same network meta-analysis that ranked light therapy first graded the evidence behind that ranking as very low quality, which means new trials could move it [15]. Reviews of the clinical literature point to small participant groups, methodological flaws and industry funding behind many of the positive results [3].

The harder problem is that no two studies use the same settings. A review of 90 reports published between 1985 and 2015 found major inconsistencies in the light parameters researchers chose, so a result from one device is a poor guide to another [11]. Whether LED sources do the same thing as the lasers used in most of the higher-quality trials is still unresolved [3], and that is exactly where consumers spend money, on LED helmets, masks and beds.

The evidence does not cover:

• hair loss that is not pattern baldness, since the trials pooled in both meta-analyses were in androgenetic alopecia [13][15]
• scarring hair loss, where the follicle is replaced rather than shrunken, because the review of these regrowth methods deals only with non-scarring types [8]
• hair loss caused by cancer treatment, where only two clinical trials have included these patients, reporting higher hair counts and better quality of life, and no professional body has issued guidance on when it is appropriate to start [5]
• darker skin tones specifically, where a dermatology review notes that red and near-infrared light can produce different biological effects across skin types and advises tailored counselling [2]

Minoxidil, finasteride and dutasteride appear here only as the comparison treatments the trials used. Finasteride and dutasteride are prescription medicines, and minoxidil produced more drug-related adverse event reports than any other treatment in that review [15], so whether any of them is appropriate is a conversation to have with a doctor.

Red light therapy is one of the more widely listed services in the Longevinsights clinic directory: 24 clinics across 21 cities offer it. As an appointment it is non-invasive, with no needles and no drugs, just timed exposure to light from a laser or LED device, and dermatologists now see it used both in the clinic and at home [2].

What the trials did not test is the equipment most clinics own. They aimed light at the scalp, over months: the six-month study used a helmet worn for 20 minutes a session [1], and the device carrying a regulatory clearance for hair loss is a comb [13]. That makes the useful questions for a clinic quite specific - which device, what wavelength, whether it is built for the scalp, and how long the course runs. Those are the variables the published research turns on, and the ones it reports least consistently [11].